Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Naringenin: A prospective therapeutic agent for Alzheimer's and Parkinson's disease
Ahsas Goyal, Aanchal Verma, Nandini Dubey, et al.
Journal of Food Biochemistry (2022) Vol. 46, Iss. 12
Closed Access | Times Cited: 48

Showing 1-25 of 48 citing articles:

Flavonoids: Their putative neurologic roles, epigenetic changes, and gut microbiota alterations in Parkinson’s disease
Yasemin Açar, Duygu Ağagündüz, Paola De Cicco, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 168, pp. 115788-115788
Open Access | Times Cited: 77
Phytochemical Properties, Extraction, and Pharmacological Benefits of Naringin: A Review
VS Shilpa, Rafeeya Shams, Kshirod Kumar Dash, et al.
Molecules (2023) Vol. 28, Iss. 15, pp. 5623-5623
Open Access | Times Cited: 69
The neuroprotective mechanisms of naringenin: Inhibition of apoptosis through the PI3K/AKT pathway after hypoxic-ischemic brain damage
Luyao Li, Zhen Lin, Junhui Yuan, et al.
Journal of Ethnopharmacology (2023) Vol. 318, pp. 116941-116941
Closed Access | Times Cited: 38
Naringenin and Hesperidin as Promising Alternatives for Prevention and Co-Adjuvant Therapy for Breast Cancer
Maria Beatriz Madureira, Virgínia Márcia Concato, Ellen Mayara Souza Cruz, et al.
Antioxidants (2023) Vol. 12, Iss. 3, pp. 586-586
Open Access | Times Cited: 35
Mechanisms of ferroptosis regulating oxidative stress and energy metabolism in myocardial ischemia-reperfusion injury and a novel perspective of natural plant active ingredients for its treatment
Tianqing Zhang, Wenxu Deng, Ying Deng, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 114706-114706
Open Access | Times Cited: 35
Regulatory mechanism and therapeutic potentials of naringin against inflammatory disorders
Peng Yuan, Ruyi Qu, Shuqin Xu, et al.
Heliyon (2024) Vol. 10, Iss. 3, pp. e24619-e24619
Open Access | Times Cited: 10
Phytomedicine for neurodegenerative diseases: The road ahead
Dev Madhubala, Aparup Patra, Mojibur R. Khan, et al.
Phytotherapy Research (2024) Vol. 38, Iss. 6, pp. 2993-3019
Closed Access | Times Cited: 10
Luteolin: Nature's promising warrior against Alzheimer's and Parkinson's disease
Ahsas Goyal, Kunal Solanki, Aanchal Verma
Journal of Biochemical and Molecular Toxicology (2023) Vol. 38, Iss. 1
Closed Access | Times Cited: 19
Naringenin ameliorates vascular senescence and atherosclerosis involving SIRT1 activation
Jie Wang, Ruoman Wu, Yi-qiao Hua, et al.
Journal of Pharmacy and Pharmacology (2023) Vol. 75, Iss. 8, pp. 1021-1033
Closed Access | Times Cited: 15
Underlying Mechanisms of Brain Aging and Neurodegenerative Diseases as Potential Targets for Preventive or Therapeutic Strategies Using Phytochemicals
Hamid M. Abdolmaleky, Jin‐Rong Zhou
Nutrients (2023) Vol. 15, Iss. 15, pp. 3456-3456
Open Access | Times Cited: 13
Therapeutic Potential of Capsaicin in Various Neurodegenerative Diseases with Special Focus on Nrf2 Signaling
Vibhav Varshney, Abhishek Kumar, Vikas Parashar, et al.
Current Pharmaceutical Biotechnology (2024) Vol. 25, Iss. 13, pp. 1693-1707
Closed Access | Times Cited: 5
Beyond Insulin: The Intriguing Role of GLP-1 in Parkinson's Disease
Aanchal Verma, Ahsas Goyal
European Journal of Pharmacology (2024) Vol. 982, pp. 176936-176936
Closed Access | Times Cited: 5
Recent advances and prospects in naringin nanocarrier drug delivery system for cancer management
Rohitas Deshmukh, Mahendra Kumar Prajapati, Ranjit K. Harwansh
Journal of Drug Delivery Science and Technology (2023) Vol. 91, pp. 105182-105182
Closed Access | Times Cited: 11
Exendin‐4: A potential therapeutic strategy for Alzheimer's disease and Parkinson's disease
Aanchal Verma, Shobhit Chaudhary, Kunal Solanki, et al.
Chemical Biology & Drug Design (2023) Vol. 103, Iss. 1
Closed Access | Times Cited: 11
Revolutionizing Parkinson’s treatment: Harnessing the potential of intranasal nanoemulsions for targeted therapy
Gulshan Sharma, Karan Wadhwa, Shobhit Kumar, et al.
Drug Delivery and Translational Research (2025)
Closed Access
Analysis of skeletal diversity of multi-target directed ligands (MTDLs) targeting Alzheimer’s disease
Uzma Azam, Muhammad Moazzam Naseer, Christophe Rochais
European Journal of Medicinal Chemistry (2025) Vol. 286, pp. 117277-117277
Open Access
Trojan Horse Delivery Strategies of Natural Medicine Monomers: Challenges and Limitations in Improving Brain Targeting
Kelu Lei, Lanyu Zhou, M. Bostenaru Dan, et al.
Pharmaceutics (2025) Vol. 17, Iss. 3, pp. 280-280
Open Access
Nature's Neuroprotector: Honokiol and Its Promise for Alzheimer's and Parkinson's
Ahsas Goyal, Anshika Kumari, Aanchal Verma, et al.
Brain Disorders (2025), pp. 100208-100208
Open Access
Synergistic Neuroprotective Effects of Ergothioneine and Lactoferrin in APP/PS1 Transgenic Mice and Mouse N2a Cells
Hui Li, Xiaoyu Wang, Ruirui Li, et al.
Journal of Agricultural and Food Chemistry (2025)
Closed Access
Therapeutic implications of crocin in Parkinson's disease: A review of preclinical research
Ahsas Goyal, Aanchal Verma, Anant Agrawal, et al.
Chemical Biology & Drug Design (2023) Vol. 101, Iss. 6, pp. 1229-1240
Closed Access | Times Cited: 10
Plant‐Based Dietary Patterns and Parkinson's Disease: A Prospective Analysis of the UK Biobank
Anna Tresserra‐Rimbau, Alysha S. Thompson, Nicola P. Bondonno, et al.
Movement Disorders (2023) Vol. 38, Iss. 11, pp. 1994-2004
Open Access | Times Cited: 10
Potential Role of Oxidative Stress in the Pathophysiology of Neurodegenerative Disorders
Sonia Singh, Ashima Ahuja, Shilpi Pathak
Combinatorial Chemistry & High Throughput Screening (2024) Vol. 27, Iss. 14, pp. 2043-2061
Closed Access | Times Cited: 3
Nuclear Factor Kappa B: A Nobel Therapeutic Target of Flavonoids Against Parkinson's Disease
Niraj Kumar Singh, Ashini Singh, Mayank
Combinatorial Chemistry & High Throughput Screening (2024) Vol. 27, Iss. 14, pp. 2062-2077
Closed Access | Times Cited: 3
Neuroprotective effects of flavonoids: endoplasmic reticulum as the target
Bita Amiri, Maryam Yazdani Tabrizi, Mahdyieh Naziri, et al.
Frontiers in Neuroscience (2024) Vol. 18
Open Access | Times Cited: 3
Pre-clinical Evidence-based Neuroprotective Potential of Naringin against Alzheimer’s Disease-like Pathology: A Comprehensive Review
Ashini Singh, Niraj Kumar Singh
Current Pharmaceutical Biotechnology (2023) Vol. 25, Iss. 9, pp. 1112-1123
Closed Access | Times Cited: 7
Page 1 - Next Page

Scroll to top